Vimarsana
Biggest News Aggregation in the World

Page 3 - Study Chair News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Chair. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Chair Today - Breaking & Trending Today

McCarthy summons GOP factions to counter threat of a new conservative rebellion - Vimarsana News

McCarthy summons GOP factions to counter threat of a new conservative rebellion

Published: July 11, 2023

But several hard-right Republicans left the speaker's meeting less than satisfied, with several must-pass bills hanging in the balance.

Source: politico.com
Related Topics:
United StatesDan BishopSteve Womackr ArkHumpty DumptyCalifornia RepublicanStudy ChairKevin HernSteve Womack
CathWorks Announces First Patient Enrolled in Global ALL-RISE Study - Vimarsana News

CathWorks Announces First Patient Enrolled in Global ALL-RISE Study

Published: June 29, 2023

Global clinical study aims to broaden evidence base by assessing clinical and economic benefits for the FFRangio System 

Source: dicardiology.com
Related Topics:
United StatesAjayj Kirtane NewyorkRamin MousaviCathworks FfrangioJason WeidmanPresbyterian Columbia University Irving Medical CenterFrancis Hospital Heart CenterWilliam Fearon Stanford UniversityAdvancing CathLab ResultsCoronary Physiology AssessmentNorth AmericaStudy ChairColumbia University Irving Medical CenterPrincipal InvestigatorsWilliam FearonStanford UniversityAllen JeremiasFrancis HospitalHeart CenterAmir KakiJohn HospitalColumbia Interventional Cardiovascular CareChief Executive OfficerSenior Vice President
CathWorks Announces First Patient Enrolled in Global ALL-RISE Study - Vimarsana News

CathWorks Announces First Patient Enrolled in Global ALL-RISE Study

Published: June 28, 2023

/PRNewswire/ -- CathWorks announced today that the first patient has been enrolled in the Advancing Cath Lab Results with FFRangio Coronary Physiology...

Source: prnewswire.com
Related Topics:
United StatesJason WeidmanAjayj KirtaneCathworks FfrangioWilliam FearonPrnewswire CathworksRamin MousaviStanford UniversityLab ResuFrancis Hospital Heart CenterPresbyterian Columbia University Irving Medical CenterJohn HospitalNorth AmericaStudy ChairColumbia University Irving Medical CenterPrincipal InvestigatorsAllen JeremiasFrancis HospitalHeart CenterAmir KakiColumbia Interventional Cardiovascular CareChief Executive OfficerSenior Vice PresidentRenal Denervation Operating Unit
VITRAC Therapeutics to Present Phase 1 Clinical Trial Design on Novel Aurora Kinase A Inhibitor, VIC-1911, and G12C Inhibitor, Sotorasib, for KRAS G12C-Mutant Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting - Vimarsana News

VITRAC Therapeutics to Present Phase 1 Clinical Trial Design on Novel Aurora Kinase A Inhibitor, VIC-1911, and G12C Inhibitor, Sotorasib, for KRAS G12C-Mutant Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting

Published: June 5, 2023

BOSTON--(BUSINESS WIRE)--Jun 4, 2023--

Source: wsiltv.com
Related Topics:
United StatesMito KoyaSarah GoldbergThomas MyersUniversity Of Maryland Cancer CenterYale Cancer CenterEmory University Winship Cancer CenterIsaac Perlmutter Cancer CenterAmerican Society Of Clinical OncologyYale School Of MedicineYork University Perlmutter Cancer CenterUniversity Of California Davis Comprehensive Cancer CenterClinical OncologyAnnual MeetingPrincipal InvestigatorStudy ChairNew York University Perlmutter Cancer CenterCalifornia Davis Comprehensive Cancer CenterMaryland Cancer CenterYale SchoolChief Medical OfficerBusiness Wire
Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009 - Vimarsana News

Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009

Published: January 4, 2023

/PRNewswire/ -- Immunitas Therapeutics ("Immunitas"), a clinical stage precision immunotherapy company committed to discovering and developing novel,...

Source: prnewswire.com
Related Topics:
United StatesUniversity SchoolAmanda WagnerJames WooldridgeAeglea BiotherapeuticsMelissal JohnsonEli LillyUniversity Of MissouriUniversity Of IowaTulane University School Of MedicineCheckmate PharmaceuticalsClinical DevelopmentClinical Advisory BoardImmunitas TherapeuticsClinical AdvisoryLung Cancer ResearchSarah Cannon Research InstituteTennessee OncologyStudy ChairPrincipal InvestigatorRecommended PhaseChief Executive OfficerChief Medical OfficerChief Scientific OfficerImmuno Oncology Clinical